Elbit Imaging Ltd.
Elbit Imaging Ltd. (EMITF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
emitf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Elbit Imaging Ltd. (EMITF) measures how much investors pay for each dollar of the company's trailing earnings. EMITF's current PE ratio of N/A is calculated by dividing its stock price of $1.60 by its TTM earnings per share of -$0.50.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%0.0x
MedianQ3 · 75%5.8x
Max
At N/A, EMITF's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Elbit Imaging Ltd.You EMITF | $21M | N/A | — | -$0.50 |
 Aurora Spine Corporation ASAPF | $12M | N/A | — | -$0.01 |
 Biotricity, Inc. BTCY | $3M | N/A | — | -$0.39 |
 Guided Therapeutics, Inc. GTHP | $15M | N/A | — | -$0.04 |
 ImpediMed Limited IPDQF | $11M | N/A | — | -$0.01 |
 Isracann Biosciences Inc. ISCNF | $0M | N/A | — | -$0.03 |
 Izotropic Corporation IZOZF | $13M | N/A | — | -$0.05 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.40 | — | |
2024-12-31 FY2024 | — | $-0.50 | — | |
2023-12-31 FY2023 | — | $-1.86 | — | |
2022-12-31 FY2022 | — | $-0.26 | — | |
2021-12-31 FY2021 | — | $-2.24 | — | |
2020-12-31 FY2020 | 5.77x | $25.01 | — | |
2019-12-31 FY2019 | — | $-11.70 | — | |
2018-12-31 FY2018 | — | $-56.34 | — | |
2017-12-31 FY2017 | — | $-36.78 | — | |
2016-12-31 FY2016 | — | $-21.20 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Elbit Imaging Ltd. (EMITF) measures how much investors pay for each dollar of the company's trailing earnings. EMITF's current PE ratio of N/A is calculated by dividing its stock price of $1.60 by its TTM earnings per share of -$0.50.
Frequently asked questions
EMITF pe ratio · 6 questionsEMITF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.60 and TTM EPS of -$0.50. Data sourced from Financial Modeling Prep via EMITF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Elbit Imaging Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09